Stockreport

NeuBase Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

NeuBase Therapeutics, Inc.  (NBSE) 
Last neubase therapeutics, inc. earnings: 3/26 04:05 pm Check Earnings Report
PDF PITTSBURGH, April 30, 2020 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE), a preclinical-stage biotechnology company focused on developing next generati [Read more]